Globalization of pharmaceutical innovation
Here’s a copy of the talk I gave at the American Chemical Society meeting, on using patent information to track globalization:
Check out it. I think the findings will surprise you!
Using patent information to track globalization
I will be giving a talk on “Using patent information to track globalization” at the ACS conference in Anaheim next week. The talk is part of the ACS Division of Chemistry and Law session on What Can Patent Information Do For Scientists, and is based on analysis of data from DrugPatentWatch. I look forward to meeting BiotechBlog readers who may be in attendance. For those who cannot make the event, my talk will be based on my work on globalization of pharmaceutical innovation.
Featured in Fortune article on Drug Patent Challenges
Fortune magazine recently published an article on the growing trend of generic companies challenging pharmaceutical drug patents. I enjoyed working with the writer to help layout the industry landscape, and share my knowledge of drug patents and trends from DrugPatentWatch.com. It’s a good read, and it does an excellent job of laying out the legal, regulatory, and economic mess that the pharmaceutical industry has become.
DrugPatentWatch adds Paragraph IV newsfeed
DrugPatentWatch.com is proud to announce the addition of a vital new feature to it's rich collection of drug patent intelligence tools: a Paragraph IV Certification newsfeed.DrugPatentWatch adds Paragraph IV newsfeed
DrugPatentWatch.com is proud to announce the addition of a vital new feature to it's rich collection of drug patent intelligence tools: a Paragraph IV Certification newsfeed.Get updates by email
Editor
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.
and Share
Reading
Translator
© Copyright - BiotechBlog — A thinkBiotech product
Recent Comments